NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
申请人:Galapagos N.V.
公开号:EP3395802A1
公开(公告)日:2018-10-31
The present invention discloses compounds according to Formula I:
Wherein Cy, R1, L1, R3, R4, R5, La, and Ra are as defined herein.
Novel benzimidazoles according to Formula I, able to inhibit JAK are disclosed, these compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergic diseases, inflammatory diseases, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or hypersecretion of interferons.
本发明公开了符合式 I 的化合物:
其中Cy、R1、L1、R3、R4、R5、La和Ra如本文所定义。
本发明公开了能抑制 JAK 的根据式 I 的新型苯并咪唑类化合物,这些化合物可制备成药物组合物,并可用于预防和治疗包括人类在内的哺乳动物的多种疾病,包括非限制性举例的过敏性疾病、炎症性疾病、自身免疫性疾病、增殖性疾病、移植排斥反应、涉及软骨周转障碍的疾病、先天性软骨畸形和/或与 IL6 分泌过多或干扰素分泌过多有关的疾病。